IL2 and cancer: We assume that the increased level of cytokines MCP-1, VEGF, and IL-2 to a greater extent reflects the current state of the immune system, in which the activation of typical agents of the pro-inflammatory reaction, for example, IL-1β, has already passed and is suppressed by the activity of cancer cells, which is a protective mechanism for their survival.